J&J’s single-dose Covid vaccine gets approval for emergency use in India

J&J’s single-dose Covid vaccine gets approval for emergency use in India

J&J’s single-dose Covid vaccine gets approval for emergency use in India

New Delhi : India on Saturday got its first single-dose Covid vaccine with the drug regulator granting emergency-use approval to the Johnson and Johnson candidate.

J&J will work in collaboration with Hyderabad-based Biological E to supply the single-dose Covid shot in India.

Union Health Minister Mansukh Mandaviya said in a tweet, “India expands its vaccine basket! Johnson and Johnson’s single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has 5 EUA vaccines. This will further boost our nation's collective fight against #COVID19.”

Previously approved Covid shots in India are Covishield by Serum Institute, Covaxin by Bharat Biotech, Sputnik V and Moderna.

India has waived requirements of all domestic trials for foreign vaccines approved by regulators of the US, the UK, EU and Japan and for vaccines in the WHO emergency use listing.